http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070012486-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9080bfdd6669ec8390a3b44fc9eefa4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84db0fd1c6479bede1ef33a57213600b
publicationDate 2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20070012486-A
titleOfInvention Combination of organic compounds
abstract The present invention relates to a pharmaceutical combination comprising an AT 1-receptor blocker or a pharmaceutically acceptable salt thereof and an mTOR inhibitor, such as rapamycin or rapamycin derivative, optionally in the presence of a pharmaceutically acceptable carrier. .
priorityDate 2004-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504262
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426124470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65999
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6950107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91450784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71316700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431610529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600

Total number of triples: 68.